Next-generation cancer tests are being developed here in Houston, and the HBJ pulled back the curtain on how one partnership ...

Histotripsy is a non-invasive treatment, approved by the Food and Drug Administration (FDA) in 2023, that uses ultrasound energy to destroy liver tumors in a single outpatient procedure. This includes ...

Doctors have upended assumptions about a rare gut disorder by turning to one of medicine’s strangest tools, a transplant of ...

According to a Phase I study led by researchers at The University of Texas MD Anderson Cancer Center, published in Nature Medicine, the novel monoclonal antibody linavonkibart has demonstrated the ...

OMI today announced the appointment of Christopher Windham, MD, as Executive Chief Operating Officer and Chief Clinical Officer, where he will lead clinical strategy and operations as the company ...

A new report from the American Cancer Association predicts lung cancer will cause more deaths than any other in 2026.

Windsor resident beating the odds following devastating diagnosis and treatment for usually deadly form of pancreatic cancer.

At The University of Texas MD Anderson Cancer Center, our mission has always been clear: to end cancer. Achieving this goal requires more than just groundbreaking research and exceptional patient care ...

NEW YORK – A team of researchers at MD Anderson Cancer Center in Houston has received $1.6 million from the state of Texas to test an intrathecal adoptive cell therapy in melanoma patients with ...

Baptist MD Anderson Cancer Center is pursuing three construction permits for projects totaling $14.44 million to renovate and expand its infusion services. The Haskell Co. of Jacksonville is listed as ...

Ochsner Health is expanding its partnership with The University of Texas MD Anderson Cancer Center to Slidell Memorial Hospital, bringing one of the nation’s most advanced cancer treatment programs to ...